Baek Jong-Suep, Tan Chuan Hao, Ng Noele Kai Jing, Yeo Yee Phan, Rice Scott A, Loo Say Chye Joachim
School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Avenue, 639798, Singapore.
Nanoscale Horiz. 2018 May 1;3(3):305-311. doi: 10.1039/c7nh00167c. Epub 2018 Feb 8.
Bacteria enmeshed in an extracellular matrix, biofilms, exhibit enhanced antibiotic tolerance. Coupled with the rapid emergence of multidrug-resistant strains, the current cohorts of antibiotics are becoming ineffective. Alternative antimicrobial approaches are therefore urgently needed to overcome recalcitrant biofilm infections. Here, we propose the use of a non-toxic lipid-polymer hybrid nanoparticle (LPN) system composed of a solid polymer core (i.e. PLGA; poly lactic-co-glycolic acid) and a cationic lipid shell (i.e. DOTAP) for localized, sustained release of antimicrobial agents to bacterial biofilms. LPNs were synthesized through a simple, robust self-assembly approach. LPNs of uniform particle size (i.e. 100-130 nm), efficiently encapsulated (up to 95%) bioimaging molecules or antibiotics and provided controlled release of the latter. The cationic lipid coating enabled the LPN to anchor onto surfaces of a diverse range of Gram-positive and Gram-negative bacterial pathogens, either in the planktonic or biofilm form. Consistently, the LPN formulations reduced more than 95% of biofilm activity at concentrations that were 8 to 32-fold lower than free antibiotics. These data clearly indicate that these novel formulations could be a useful strategy to enhance the efficacy of antimicrobials against planktonic cells and biofilms of diverse species.
包裹在细胞外基质(生物膜)中的细菌表现出更强的抗生素耐受性。随着多重耐药菌株的迅速出现,现有的抗生素正在失效。因此,迫切需要替代抗菌方法来克服顽固的生物膜感染。在此,我们提出使用一种由固体聚合物核心(即聚乳酸-乙醇酸共聚物;PLGA)和阳离子脂质外壳(即二油酰基磷脂酰乙醇胺;DOTAP)组成的无毒脂质-聚合物杂化纳米颗粒(LPN)系统,用于将抗菌剂局部、持续释放到细菌生物膜中。LPN通过一种简单、可靠的自组装方法合成。粒径均匀(即100-130纳米)的LPN能够高效包封(高达95%)生物成像分子或抗生素,并能控制后者的释放。阳离子脂质涂层使LPN能够锚定在多种革兰氏阳性和革兰氏阴性细菌病原体的表面,无论是浮游形式还是生物膜形式。一致地,LPN制剂在比游离抗生素低8至32倍的浓度下可降低超过95%的生物膜活性。这些数据清楚地表明,这些新型制剂可能是一种有用的策略,可提高抗菌剂对多种物种的浮游细胞和生物膜的疗效。